What makes TRUE.CN stock a short-term bounce candidate?

TRUE.CN stock shows a sharp five-day decline of **-26.09%**, low relative volume, and price near the 200-day average **C$0.49**. That mix creates a clear risk-reward for a short-term bounce if buying interest and volume reappear

How do fundamentals affect a TRUE.CN stock bounce trade?

Fundamentals weigh heavily: EPS **-0.19**, price-to-sales **73.52**, and current ratio **0.09** indicate liquidity and valuation risk. Use small sizing and a tight stop when trading a technical bounce

What price targets and stop loss should I use for TRUE.CN stock?

A prudent plan: entry near **C$0.51**, stop at **C$0.43**, initial target **C$0.68** and secondary target **C$0.85**. Adjust size for elevated risk and confirm with volume

Where can I follow updates on TRUE.CN stock and sector news?

Follow company filings and sector headlines. Meyka AI maintains a TRUE.CN tracking page and we cite major news sources for market context. Also monitor clinical and healthcare releases for sector catalysts

CA Stocks

TRUE.CN Treatment.Com CNQ C$0.51 23 Mar 2026: Oversold bounce opportunity

ByDanny Kontos March 23, 2026March 23, 2026

TRUE.CN stock is trading at C$0.51 on the TSX Venture (CNQ) in Canada as of 23 Mar 2026, setting up a classic oversold bounce scenario after a five-day decline of -26.09%. Treatment.Com International Inc. (TRUE.CN) shows a small float, daily volume near 97,081.00 shares, and a market cap of C$38,506,224.00. With EPS -0.19 and price averages near the current level, short-term traders can spot a defined risk-reward where a relief rally is plausible. This note frames the technical entry, financial context, and Meyka AI grade for TRUE.CN stock to aid a measured oversold bounce strategy